yes..this chart looks promising, even the subsidiary stock that owns...
Biovest is publicly-traded on the Over-the-Counter (OTC) market with the stock-ticker symbol “BVTI”, and is a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (Other OTC: ABPIQ)
from: where restructuring promise is coming to fruition.